CMIRX Mutual Fund

CMIRX Mutual Fund

NAV$10.29
See how much of CMIRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$3M
Expense Ratio
1.25%
Dividend Yield (Current)
0.91%
Holdings
30
Inception Date
Dec 17, 2021
Fund Family
Conestoga Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+13.11%
1 Year+10.59%
3 Year+14.94%

Asset Allocation

Stocks: 97.15%
Cash: 2.85%
See how much of CMIRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
TWSTTwist Bioscience Corp.5.87%
MMMBMamamancini's Holdings Inc4.89%
PLMRPalomar Holdings Inc4.43%
BLFSBiolife Solutions Com New4.42%
DGIIDigi International Inc4.25%
Top 10 Concentration: 43.37%Report Date: Aug 31, 2026
Download all 30 holdings for CMIRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.91%
Frequency
Annually

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

CMIRX Mutual Fund Overview

CMIRX Mutual Fund (Conestoga Discovery Fund Class Institutional) is managed by Conestoga Funds with $3.1M in net assets. CMIRX expense ratio is 1.25%, holding 30 positions across sectors including Industrials, Health Care, Information Technology. Inception date: 2021-12-17.

CMIRX performance shows a YTD return of 13.11%. The 1-year return is 10.59%. CMIRX dividend yield stands at 0.91%, paid annually.

CMIRX top holdings include Twist Bioscience Corp. (5.9%), Mamamancini's Holdings Inc (4.9%), Palomar Holdings Inc (4.4%), Biolife Solutions Com New (4.4%), Digi International Inc (4.3%). Go to all CMIRX holdings, CMIRX sectors, or CMIRX dividends.

CMIRX can be compared against other funds. Use CMIRX overlap to find shared positions, or CMIRX vs another fund for a side-by-side view. CMIRX alternatives are available via the screener, along with tax-loss harvesting opportunities.